12:00 AM
 | 
Dec 24, 2012
 |  BC Week In Review  |  Clinical News  |  Clinical Results

ISIS-PTP1BRx: Phase I data

Top-line data from a double-blind Phase I trial in 29 obese patients showed that 400 mg ISIS-PTP1BRx significantly increased mean high-molecular weight adiponectin (ADIPOQ) levels from baseline to day 29 vs. placebo (p=0.0042). The 100 and...

Read the full 169 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >